-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/improving-utility-evidence-synthesis-white-paper.pdf
April 01, 2021 - Evidence does not
indicate an optimal treatment
regimen or duration of
therapy, or identify whether … as usual,
waitlists, no treatment, or
other active treatments, in
adults with posttraumatic
stress … Improving diabetes-
related health care
utilization?
c. … Use of
Cardiac Resynchronization Therapy. … Behavioral Programs for Type 1 Diabetes
Mellitus: A Systematic Review and Meta-
analysis.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-artery-stenting_research-protocol.pdf
August 19, 2011 - Treatment options for CAD include medical therapy and invasive
revascularization with either percutaneous … times and initial costs and possibly generate
additional unnecessary invasive tests or unnecessary treatments … myocardial
infarction [STEMI], non-STEMI, unstable angina, and stable angina)
○ Patients who have diabetes … literature sources such as Scientific
Information Packages from manufacturers, Transcatheter Cardiovascular Therapeutics … Further
analyses will be stratified based on patient- and lesion-level characteristics (diabetes, length
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/deficit-hyperactivity-protocol.pdf
November 01, 2021 - therapies. … , digital gamified cognitive
therapies, EndeavorRx, play therapy, play-based
interventions, mindfulness-based … ): Specific treatments compared with
other treatments as described above or to no treatment
KQ 3 (monitoring … Therapies"[MeSH] OR "Combined Modality Therapy"[MeSH]
ADHD Systematic Review Protocol … ] OR "alternative therapy"[tiab] OR "alternative therapies"[tiab]
OR "Interpersonal skills training"
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-function_executive.pdf
August 01, 2014 - It may not be ethical to randomize or withhold
therapy based on troponin values alone, as ACS treatment … Therapeutic options
and likelihood of impact on outcomes may vary across
stages of CKD. … Many patients may already have
indications for these therapies; what additional treatment
should clinicians … next steps regarding how best to manage these patients
with elevated troponin levels (how and if treatments … would
vary from those treatments indicated by clinical factors
alone), the applicability of this screening
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_disposition-comments.pdf
September 25, 2013 - a call for a large randomized trial to evaluate
the utility of platelet function testing to guide therapeutic … and to guide antiplatelet therapy in patient
populations who are eligible for clopidogrel treatment … and to guide
antiplatelet therapy in patient populations who are eligible for
clopidogrel treatment … data which is the basis for the US-
approved clopidogrel labeling recommendation to consider
other therapies … Rather, it is very consistent with how antiplatelet
therapies are evaluated for efficacy.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-prevention_research-protocol.pdf
November 03, 2011 - What are the harms from preventive pharmacologic treatments when compared to
placebo or no active treatment … as monodrug therapy or drug
therapy combined with nonpharmacological interventions; we clarified comparators … We added a question addressing the role of dosing regimens and duration of treatments
on treatment … factors and social/family support system
– Comorbidities (depression, bipolar disorder, anxiety, diabetes … Impact of migraine and migraine therapy on productivity and
quality of life.
-
effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1406.pdf
February 01, 2015 - , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … predominantly symptom-
management options; however, emerging research aims to identify disease-modifying therapies … AD pathogenesis, leading researchers to investigate intranasally delivered insulin as a
potential therapy … Food and Drug
Administration (FDA) for treating diabetes, including Humulin® and Humulin R® (Eli Lilly … Intranasal
insulin therapy for Alzheimer disease and
amnestic mild cognitive impairment: a pilot
-
effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual_130826.pdf
August 01, 2013 - Diabetes mellitus
8. Functional limitations and disability
9. … Potential to change current treatment models
6. … cardiovascular
medicine professionals; reports on
emerging technologies, techniques and
medical therapies … X X X X X X X
Diabetes Technology &
Therapeutics
1, 4, 5, 7
Monthly journal that publishes scientific … treatments.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/obesity-research-methods_research-protocol.pdf
February 08, 2017 - with the control group, the group with the voucher had a lower prevalence of extreme obesity
and diabetes … stratifying by subgroups: age, race/ethnicity, gender, rural/urban, or clinical conditions
(e.g., type 2 diabetes … , pre-diabetes, elevated cardiovascular risk). … selection bias or endogeneity, a term used by
economists for treatment selection bias. … Neighborhoods, obesity, and diabetes--a
randomized social experiment.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-surgery-preparation_research-protocol.pdf
March 26, 2013 - OMBP is also routinely prescribed prior to
colonoscopy (screening, diagnostic, and therapeutic) to allow … elderly (≥65 years of age) and those with comorbidities
such as cardiovascular and pulmonary disease, diabetes … the elderly), patients who
have undergone adjuvant chemotherapy or radiotherapy, and patients with diabetes … We will
also report probabilities that the difference (in the odds ratio scale) between pairs of treatments … Simultaneous comparison of multiple treatments:
combining direct and indirect evidence.
-
effectivehealthcare.ahrq.gov/sites/default/files/fecal-incontinence_disposition-comments.pdf
March 21, 2016 - increasing age, female sex,
chronic diarrhea, nerve damage (from injury, multiple
sclerosis, or chronic diabetes … We edited the
statement to read: Treatments for FI are
imperfect and treatment combinations are
common … Treatments for FI
are imperfect and treatment combinations are
common. … Combination therapy with biofeedback, loperamide, and
stool-bulking agents is effective for the treatment … engaging patients in a conversation about risks
and benefits of each therapeutic option is important
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-treatment-future_research.pdf
September 01, 2012 - First,
this area of research – the use of breathing techniques and even complementary and alternative
therapies … agenda related to the use of breathing techniques and exercises and other
complementary and alternative therapies … Kuwait:
Dasman Diabetes Institute; 2012.
http://clinicaltrials.gov/ct2/show/NCT01509
443. … Heart rate variability
biofeedback: its role in asthma therapeutics. … research, new-to-the-field thinking
o Relevance to asthma: potential for new insights into causes
and treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/major-depressive-disorder_research-protocol.pdf
November 24, 2014 - increases the likelihood of chronic conditions such as obesity, smoking,
sedentary lifestyles, diabetes … , cognitive therapy, cognitive behavioral
therapy, interpersonal therapy, psychodynamic therapies, and … other talk therapies. … The efficacy of light therapy in the
treatment of mood disorders: a review and meta-analysis of the … just SGAs
and nonpharmacological
therapies, they include
all of the treatment
comparisons of KQ1
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/fatty-acids-cardiovascular-disease_executive.pdf
August 01, 2016 - There have been secular trends in the prevention
and treatment of CVD over the past several decades, … trends are
the lower rates of cardiac and cerebrovascular disease,
concomitant with higher rates of treatment … These treatment trends may have contributed
to the lower population-level CV benefit of higher n-3 FA … , hormone replacement
therapy)? … , hormone replacement therapy)?
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-protocol.pdf
December 01, 2011 - Diabetes mellitus
8. Functional limitations and disability
9. … Potential to change current treatment models
b. … cardiovascular
medicine professionals; reports on
emerging technologies, techniques and
medical therapies … X X X X X X X
Diabetes Technology &
Therapeutics
1, 4, 5, 7
Monthly journal that publishes scientific … treatments.
-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1412.pdf
December 01, 2014 - new (and new uses of existing) pharmaceuticals, medical
devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … ulcerative colitis), and we
continue tracking novel drugs and interventions such as fecal microbiota therapy … at-home intravenous PN support for
SBS, the manufacturer estimates the number of candidates for this therapy … Bethesda (MD): National
Institute of Diabetes and Digestive and Kidney
Diseases (NIDDK), National
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/copd-research-protocol.pdf
April 11, 2018 - Examples of emerging treatments for AECOPD, some of which may have an established
role in the treatment … from systemic
corticosteroids, in particular hyperglycemia, in patients with glucose intolerance and
diabetes … will focus on evidence
from randomized controlled trials as the gold standard design for evaluating a therapeutic … / or exp Psychotherapy/ or exp Cognitive Therapy/ or exp Cognitive
6840812
Behavior Therapy/ or … Therapies/ or exp Electric
Stimulation Therapy/
7
((action adj3 plan*) or (disease adj2 manag*)
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/observational-research-scores_research.pdf
May 01, 2012 - treatments). … , including the expected beneficial therapeutic effect as well as
adverse effects of the treatment. … of adherence to
prior therapies, particularly if adherence to therapy can affect the safety or effectiveness … Since they are not in fact candidates for one of the treatments, comparisons of
treatment effectiveness … Clinical
Pharmacology & Therapeutics
2004;75:234–241.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/congestive-heart-failure-medicines_research.pdf
March 01, 2010 - for very severe HF that had proven refractory to other
treatments. … A review of uses of
health care utilization databases for
epidemiologic research on therapeutics. … Hypertension (uncomplicated) 73.7% 84 <.0001
Hypertension (complicated) 8.5% 18 <.0001
Diabetes … (uncomplicated) 39.7% 54 <.0001
Diabetes (complicated) 15.3% 27 <.0001
Hypothyroidism 5.1% … Mortality hazard ratios for receipt of selected heart failure therapies or combinations versus no therapy
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-200-comments-post-acs.pdf
November 14, 2017 - "Alternative therapies". Alternative may
have negative connotations. … Consider a different word
such as "Other therapies....". … We have replaced with “Other
therapies.”
38. … the drugs if the patient preferred an antidepressant, or the
patient was provided problem solving therapy … very important to highlight the trial of "blended"
collaborative care for depression and co-morbid diabetes